Ten Months On, Abbott, Wockhardt Terminate Deal For Nutritional Business
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Pharmaceuticals-to-diagnostics giant Abbott and debt-ridden Indian drug maker Wockhardt jointly agreed to call off the $130 million deal for a nutritional business that the two had announced barely 10 months ago
You may also be interested in...
INTERVIEW: Abbott Nutrition Revs Up For Bigger India Play
A combination of factors is aiding Abbott Nutrition’s pitch for a bigger slice of the evolving Indian nutrition market. The company is already growing at a rate far higher than the industry average of 12%, a pace it expects to maintain for the next few years.
INTERVIEW: Abbott Nutrition Revs Up For Bigger India Play
A combination of factors is aiding Abbott Nutrition’s pitch for a bigger slice of the evolving Indian nutrition market. The company is already growing at a rate far higher than the industry average of 12%, a pace it expects to maintain for the next few years.
Danone Gets Second Time Lucky, Buys Wockhardt's Nutrition Brands That Abbott Had Won And Lost
HYDERABAD, India - After several months of discussions, debt-laden Indian drug maker Wockhardt Ltd. finally managed to sell its growing nutritional business to French food giant Group Danone for reportedly $354 million - a quantum jump from the $130 million that Abbott Laboratories Ltd. had agreed to pay for the same assets exactly two years ago